Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 28, 2020 at 09:05 am EDT
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 1,205.779 million compared to CNY 1,179.364 million a year ago. Operating income was CNY 316.497 million compared to CNY 376.682 million a year ago. Net income was CNY 273.963 million compared to CNY 320.251 million a year ago. Basic earnings per share from continuing operations was CNY 0.64 compared to CNY 0.76 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
